Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurosurgery | 12 | 2021 | 670 | 2.190 |
Why?
|
Intracranial Aneurysm | 27 | 2023 | 1276 | 1.690 |
Why?
|
Subarachnoid Hemorrhage | 17 | 2020 | 1031 | 1.090 |
Why?
|
Endovascular Procedures | 9 | 2021 | 2140 | 1.010 |
Why?
|
Colloid Cysts | 2 | 2020 | 6 | 0.930 |
Why?
|
Vasospasm, Intracranial | 2 | 2020 | 215 | 0.770 |
Why?
|
Nicardipine | 1 | 2020 | 60 | 0.710 |
Why?
|
Carotid Artery Injuries | 2 | 2022 | 96 | 0.690 |
Why?
|
Verapamil | 1 | 2020 | 242 | 0.680 |
Why?
|
Aneurysm, Ruptured | 4 | 2018 | 459 | 0.660 |
Why?
|
Brain Ischemia | 17 | 2021 | 3047 | 0.630 |
Why?
|
Intracranial Arteriovenous Malformations | 6 | 2020 | 366 | 0.600 |
Why?
|
Hydrocephalus | 2 | 2020 | 763 | 0.570 |
Why?
|
Arterial Occlusive Diseases | 8 | 2021 | 747 | 0.560 |
Why?
|
Athletic Injuries | 5 | 2014 | 1212 | 0.540 |
Why?
|
Vasodilator Agents | 1 | 2020 | 973 | 0.520 |
Why?
|
Blood Vessel Prosthesis | 2 | 2015 | 953 | 0.500 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2017 | 140 | 0.500 |
Why?
|
Cerebral Hemorrhage | 7 | 2022 | 2650 | 0.470 |
Why?
|
Ischemic Attack, Transient | 11 | 2005 | 878 | 0.470 |
Why?
|
Thrombectomy | 5 | 2021 | 690 | 0.460 |
Why?
|
Accreditation | 1 | 2017 | 472 | 0.450 |
Why?
|
Certification | 1 | 2017 | 418 | 0.450 |
Why?
|
Cerebral Angiography | 16 | 2022 | 1275 | 0.420 |
Why?
|
Cerebral Revascularization | 4 | 2006 | 250 | 0.410 |
Why?
|
Neurosurgical Procedures | 7 | 2020 | 2054 | 0.390 |
Why?
|
Sports Medicine | 1 | 2014 | 243 | 0.390 |
Why?
|
Wounds, Nonpenetrating | 4 | 2022 | 794 | 0.360 |
Why?
|
Spinal Cord | 2 | 2017 | 1815 | 0.360 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2011 | 56 | 0.360 |
Why?
|
Spinal Cord Neoplasms | 2 | 2010 | 262 | 0.360 |
Why?
|
Cerebral Arteries | 7 | 2000 | 490 | 0.350 |
Why?
|
Hemangioma, Cavernous | 1 | 2010 | 107 | 0.340 |
Why?
|
Estradiol | 12 | 2005 | 1933 | 0.340 |
Why?
|
Schools, Medical | 1 | 2016 | 877 | 0.330 |
Why?
|
Carotid Artery, Internal | 5 | 2021 | 435 | 0.310 |
Why?
|
Ophthalmic Artery | 3 | 2005 | 58 | 0.300 |
Why?
|
Spinal Injuries | 3 | 2006 | 300 | 0.300 |
Why?
|
Neuroprotective Agents | 8 | 2011 | 956 | 0.300 |
Why?
|
Faculty, Medical | 1 | 2016 | 1192 | 0.300 |
Why?
|
Cerebrovascular Trauma | 2 | 2018 | 22 | 0.300 |
Why?
|
Stroke | 5 | 2022 | 9695 | 0.290 |
Why?
|
Cerebral Arterial Diseases | 2 | 2021 | 82 | 0.280 |
Why?
|
Infarction, Middle Cerebral Artery | 7 | 2006 | 485 | 0.270 |
Why?
|
Basilar Artery | 3 | 1998 | 204 | 0.270 |
Why?
|
Stents | 3 | 2022 | 3162 | 0.270 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2354 | 0.260 |
Why?
|
Craniotomy | 3 | 1998 | 741 | 0.250 |
Why?
|
Specialization | 2 | 2004 | 776 | 0.240 |
Why?
|
Meningitis, Fungal | 1 | 2023 | 3 | 0.230 |
Why?
|
Lumbar Vertebrae | 5 | 2009 | 1865 | 0.230 |
Why?
|
Governing Board | 1 | 2004 | 50 | 0.230 |
Why?
|
Choroid Plexus Neoplasms | 1 | 2023 | 38 | 0.220 |
Why?
|
Brain Edema | 3 | 2018 | 602 | 0.220 |
Why?
|
Brain Injuries | 1 | 2014 | 2045 | 0.210 |
Why?
|
Autonomic Nerve Block | 1 | 2003 | 80 | 0.210 |
Why?
|
Heat Stroke | 1 | 2002 | 29 | 0.210 |
Why?
|
Methylprednisolone | 1 | 2023 | 384 | 0.200 |
Why?
|
Astrocytoma | 2 | 2022 | 775 | 0.200 |
Why?
|
Organizational Objectives | 1 | 2004 | 426 | 0.200 |
Why?
|
Internship and Residency | 3 | 2021 | 5854 | 0.200 |
Why?
|
Quality Improvement | 1 | 2017 | 3793 | 0.190 |
Why?
|
Humans | 88 | 2023 | 757566 | 0.190 |
Why?
|
Cerebrovascular Disorders | 2 | 1999 | 1475 | 0.190 |
Why?
|
Clinical Competence | 1 | 2017 | 4760 | 0.190 |
Why?
|
Science | 1 | 2004 | 239 | 0.190 |
Why?
|
Professional Competence | 1 | 2004 | 430 | 0.180 |
Why?
|
Pseudotumor Cerebri | 1 | 2022 | 108 | 0.180 |
Why?
|
Carotid Stenosis | 2 | 2006 | 853 | 0.180 |
Why?
|
Surgical Instruments | 3 | 2015 | 382 | 0.180 |
Why?
|
Infusions, Intra-Arterial | 1 | 2020 | 222 | 0.170 |
Why?
|
Middle Cerebral Artery | 5 | 2023 | 275 | 0.170 |
Why?
|
Anterior Cerebral Artery | 3 | 2021 | 50 | 0.170 |
Why?
|
Fibrinolytic Agents | 2 | 2021 | 2070 | 0.170 |
Why?
|
Intracranial Hypertension | 1 | 2022 | 193 | 0.170 |
Why?
|
Reperfusion Injury | 5 | 2005 | 1023 | 0.170 |
Why?
|
Efficiency, Organizational | 1 | 2004 | 695 | 0.160 |
Why?
|
Nitroglycerin | 1 | 2020 | 328 | 0.160 |
Why?
|
Blood Coagulation Disorders | 1 | 2022 | 349 | 0.160 |
Why?
|
Credentialing | 1 | 2019 | 115 | 0.160 |
Why?
|
Evoked Potentials, Somatosensory | 3 | 1991 | 246 | 0.160 |
Why?
|
Treatment Outcome | 16 | 2022 | 64242 | 0.160 |
Why?
|
Middle Aged | 42 | 2023 | 219192 | 0.160 |
Why?
|
Research Design | 1 | 2014 | 6152 | 0.150 |
Why?
|
Female | 64 | 2023 | 389943 | 0.150 |
Why?
|
Physicians | 1 | 2016 | 4577 | 0.150 |
Why?
|
Angioplasty, Balloon | 1 | 2022 | 588 | 0.150 |
Why?
|
Aneurysm | 2 | 2015 | 336 | 0.150 |
Why?
|
Embolization, Therapeutic | 2 | 2021 | 1406 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 16 | 2022 | 20499 | 0.150 |
Why?
|
Estrogens | 3 | 2002 | 1519 | 0.150 |
Why?
|
Consensus | 2 | 2017 | 3097 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 584 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10135 | 0.140 |
Why?
|
Pons | 1 | 1998 | 239 | 0.140 |
Why?
|
Behavior, Animal | 1 | 2004 | 1868 | 0.140 |
Why?
|
Mesencephalon | 1 | 1998 | 332 | 0.130 |
Why?
|
Trauma Severity Indices | 1 | 2018 | 478 | 0.130 |
Why?
|
Male | 54 | 2023 | 358180 | 0.130 |
Why?
|
Cerebellum | 2 | 2002 | 1497 | 0.130 |
Why?
|
Vascular Surgical Procedures | 3 | 2015 | 1472 | 0.130 |
Why?
|
Epilepsy | 1 | 2011 | 3270 | 0.130 |
Why?
|
Incidental Findings | 1 | 2020 | 693 | 0.130 |
Why?
|
Melatonin | 2 | 2013 | 668 | 0.130 |
Why?
|
Medicine | 1 | 2004 | 940 | 0.130 |
Why?
|
Disease Progression | 4 | 2020 | 13463 | 0.120 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1156 | 0.120 |
Why?
|
Brain Stem | 2 | 2020 | 857 | 0.120 |
Why?
|
Stem Cells | 2 | 2005 | 3521 | 0.120 |
Why?
|
Brain Neoplasms | 4 | 2022 | 8981 | 0.120 |
Why?
|
Porosity | 1 | 2015 | 348 | 0.120 |
Why?
|
Adult | 32 | 2023 | 219725 | 0.120 |
Why?
|
Florida | 1 | 2016 | 425 | 0.120 |
Why?
|
Multiple Trauma | 1 | 2017 | 369 | 0.120 |
Why?
|
Intermediate Filament Proteins | 2 | 2005 | 262 | 0.120 |
Why?
|
Cell Death | 5 | 2013 | 1666 | 0.120 |
Why?
|
History, 20th Century | 2 | 2016 | 2769 | 0.110 |
Why?
|
Temporal Bone | 1 | 1998 | 683 | 0.110 |
Why?
|
Arteriovenous Fistula | 1 | 2017 | 313 | 0.110 |
Why?
|
Equipment Failure Analysis | 1 | 2015 | 842 | 0.110 |
Why?
|
Antioxidants | 2 | 2013 | 1665 | 0.110 |
Why?
|
Rupture, Spontaneous | 4 | 2005 | 353 | 0.110 |
Why?
|
Carotid Artery Diseases | 2 | 1998 | 872 | 0.110 |
Why?
|
Postoperative Complications | 11 | 2009 | 15532 | 0.110 |
Why?
|
Headache | 2 | 2020 | 1249 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 15 | 2005 | 8143 | 0.100 |
Why?
|
Rats | 21 | 2005 | 23676 | 0.100 |
Why?
|
Cytochromes c | 2 | 2013 | 173 | 0.100 |
Why?
|
General Surgery | 1 | 2004 | 1674 | 0.100 |
Why?
|
Aged | 30 | 2023 | 167890 | 0.100 |
Why?
|
Posterior Cerebral Artery | 1 | 2012 | 35 | 0.100 |
Why?
|
Dipyrone | 1 | 2011 | 9 | 0.100 |
Why?
|
Cerebrovascular Circulation | 9 | 2007 | 2725 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2330 | 0.100 |
Why?
|
Pituitary Gland | 2 | 2011 | 637 | 0.100 |
Why?
|
Microsurgery | 2 | 2015 | 793 | 0.100 |
Why?
|
Neurons | 8 | 2011 | 9418 | 0.090 |
Why?
|
Sella Turcica | 1 | 2011 | 118 | 0.090 |
Why?
|
Endarterectomy | 4 | 1987 | 195 | 0.090 |
Why?
|
Universities | 1 | 2016 | 986 | 0.090 |
Why?
|
Cerebral Infarction | 4 | 2003 | 982 | 0.090 |
Why?
|
Football | 2 | 2006 | 502 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 2019 | 2060 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1568 | 0.090 |
Why?
|
Cerebral Veins | 1 | 2011 | 157 | 0.090 |
Why?
|
Paresis | 2 | 1989 | 176 | 0.090 |
Why?
|
Disease Management | 1 | 2020 | 2495 | 0.090 |
Why?
|
Retrospective Studies | 12 | 2023 | 79984 | 0.080 |
Why?
|
Methazolamide | 1 | 2009 | 9 | 0.080 |
Why?
|
Perfusion Imaging | 2 | 2021 | 196 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2002 | 3387 | 0.080 |
Why?
|
Brain | 7 | 2006 | 26952 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2020 | 12047 | 0.080 |
Why?
|
Oculomotor Nerve | 1 | 1989 | 72 | 0.080 |
Why?
|
Ovariectomy | 6 | 2003 | 610 | 0.080 |
Why?
|
Lasers | 3 | 1987 | 951 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2015 | 2105 | 0.080 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2009 | 91 | 0.080 |
Why?
|
Carotid Artery Thrombosis | 1 | 1987 | 50 | 0.070 |
Why?
|
Neoplasms, Vascular Tissue | 1 | 1987 | 25 | 0.070 |
Why?
|
Young Adult | 6 | 2022 | 58755 | 0.070 |
Why?
|
Bromodeoxyuridine | 2 | 2005 | 311 | 0.070 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1987 | 144 | 0.070 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2011 | 352 | 0.070 |
Why?
|
Spinal Cord Diseases | 1 | 2010 | 293 | 0.070 |
Why?
|
Blood-Brain Barrier | 2 | 2005 | 1017 | 0.070 |
Why?
|
Hypothalamic Neoplasms | 1 | 2007 | 21 | 0.070 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1987 | 64 | 0.070 |
Why?
|
Hippocampus | 3 | 2005 | 3739 | 0.070 |
Why?
|
Carotid Arteries | 3 | 1989 | 939 | 0.070 |
Why?
|
Athletes | 1 | 2014 | 1125 | 0.070 |
Why?
|
Testosterone | 3 | 2005 | 2465 | 0.070 |
Why?
|
Spondylolysis | 1 | 2006 | 46 | 0.070 |
Why?
|
Hemorrhage | 3 | 2021 | 3399 | 0.070 |
Why?
|
Eye Injuries | 1 | 1989 | 227 | 0.070 |
Why?
|
Temporal Arteries | 2 | 2023 | 148 | 0.070 |
Why?
|
Age Factors | 3 | 2020 | 18326 | 0.060 |
Why?
|
Optic Nerve Diseases | 1 | 1989 | 342 | 0.060 |
Why?
|
Vision Disorders | 2 | 1990 | 1084 | 0.060 |
Why?
|
Blood Pressure | 7 | 2006 | 8453 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9245 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 6 | 2020 | 36270 | 0.060 |
Why?
|
Neuroma | 1 | 2006 | 133 | 0.060 |
Why?
|
Spinal Neoplasms | 1 | 2011 | 714 | 0.060 |
Why?
|
Radiography | 6 | 2008 | 6956 | 0.060 |
Why?
|
History, 19th Century | 1 | 2006 | 720 | 0.060 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2009 | 841 | 0.060 |
Why?
|
Cell Count | 2 | 2005 | 1834 | 0.060 |
Why?
|
Laser Therapy | 2 | 1987 | 1082 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 1994 | 2167 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3480 | 0.060 |
Why?
|
Adolescent | 10 | 2022 | 87819 | 0.060 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2000 | 1109 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 4 | 2009 | 609 | 0.060 |
Why?
|
Circle of Willis | 1 | 2023 | 78 | 0.050 |
Why?
|
Superior Cervical Ganglion | 1 | 2003 | 33 | 0.050 |
Why?
|
Intraoperative Complications | 3 | 2007 | 1165 | 0.050 |
Why?
|
Arteriosclerosis | 2 | 2003 | 1055 | 0.050 |
Why?
|
Estradiol Congeners | 1 | 2002 | 23 | 0.050 |
Why?
|
Disease Models, Animal | 9 | 2013 | 18114 | 0.050 |
Why?
|
Posture | 2 | 2004 | 954 | 0.050 |
Why?
|
United States | 7 | 2021 | 71902 | 0.050 |
Why?
|
Proestrus | 1 | 2002 | 14 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2005 | 4407 | 0.050 |
Why?
|
Caspase 3 | 3 | 2013 | 728 | 0.050 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2013 | 1462 | 0.050 |
Why?
|
Angiography, Digital Subtraction | 2 | 2018 | 335 | 0.050 |
Why?
|
Craniocerebral Trauma | 1 | 2006 | 490 | 0.050 |
Why?
|
Corpus Callosum | 1 | 2007 | 749 | 0.050 |
Why?
|
Constriction, Pathologic | 2 | 2022 | 1097 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 8946 | 0.050 |
Why?
|
Cranial Sinuses | 1 | 2022 | 68 | 0.050 |
Why?
|
Amphetamines | 1 | 2002 | 143 | 0.050 |
Why?
|
Calpain | 1 | 2002 | 145 | 0.050 |
Why?
|
Spinal Diseases | 1 | 1987 | 559 | 0.050 |
Why?
|
Vision, Ocular | 1 | 2005 | 454 | 0.050 |
Why?
|
Estrone | 1 | 2002 | 232 | 0.050 |
Why?
|
Adamantane | 1 | 2002 | 146 | 0.050 |
Why?
|
Cohort Studies | 6 | 2021 | 41190 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2267 | 0.050 |
Why?
|
Mexico | 1 | 2023 | 758 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39020 | 0.050 |
Why?
|
Risk Factors | 7 | 2020 | 73708 | 0.050 |
Why?
|
Animals | 28 | 2013 | 167718 | 0.050 |
Why?
|
Time Factors | 7 | 2017 | 39811 | 0.050 |
Why?
|
Aneurysm, Infected | 1 | 1981 | 81 | 0.050 |
Why?
|
Vertebral Artery | 1 | 2022 | 185 | 0.050 |
Why?
|
Risk Assessment | 2 | 2020 | 23816 | 0.050 |
Why?
|
Awareness | 1 | 2005 | 642 | 0.050 |
Why?
|
Hematoma | 2 | 2022 | 768 | 0.050 |
Why?
|
Carotid Sinus | 1 | 1980 | 44 | 0.050 |
Why?
|
Glutamates | 1 | 2002 | 389 | 0.040 |
Why?
|
Behavioral Symptoms | 1 | 2002 | 186 | 0.040 |
Why?
|
Iatrogenic Disease | 1 | 2023 | 538 | 0.040 |
Why?
|
Registries | 1 | 2016 | 8164 | 0.040 |
Why?
|
Creatine | 1 | 2002 | 426 | 0.040 |
Why?
|
Hypotension | 1 | 1986 | 880 | 0.040 |
Why?
|
Spinal Fractures | 1 | 2006 | 702 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 640 | 0.040 |
Why?
|
Internal Capsule | 1 | 2000 | 138 | 0.040 |
Why?
|
Retreatment | 1 | 2021 | 596 | 0.040 |
Why?
|
Physician's Role | 1 | 2006 | 916 | 0.040 |
Why?
|
Spinal Fusion | 1 | 2009 | 1278 | 0.040 |
Why?
|
Hypothermia, Induced | 1 | 2005 | 756 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14473 | 0.040 |
Why?
|
Vascular Patency | 1 | 2002 | 895 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2005 | 939 | 0.040 |
Why?
|
Chondroma | 1 | 1998 | 53 | 0.040 |
Why?
|
Petrous Bone | 1 | 1998 | 84 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2013 | 6230 | 0.040 |
Why?
|
Neurotoxicity Syndromes | 1 | 2002 | 300 | 0.040 |
Why?
|
Dizocilpine Maleate | 1 | 1998 | 172 | 0.040 |
Why?
|
Antigens, CD | 1 | 2008 | 3996 | 0.040 |
Why?
|
Brain Infarction | 1 | 1999 | 290 | 0.040 |
Why?
|
Forecasting | 2 | 1999 | 2919 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2023 | 1114 | 0.040 |
Why?
|
Skull Neoplasms | 1 | 1998 | 173 | 0.040 |
Why?
|
Stress, Physiological | 1 | 2005 | 1399 | 0.040 |
Why?
|
Infant | 4 | 2018 | 36045 | 0.040 |
Why?
|
Cavernous Sinus | 1 | 1998 | 123 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15207 | 0.040 |
Why?
|
Blotting, Western | 3 | 2011 | 5031 | 0.040 |
Why?
|
Independent Living | 1 | 2021 | 567 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 1998 | 8545 | 0.030 |
Why?
|
Thromboembolism | 1 | 2003 | 995 | 0.030 |
Why?
|
Oligopeptides | 1 | 2002 | 1184 | 0.030 |
Why?
|
Cerebral Cortex | 3 | 2003 | 5756 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10477 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2003 | 1431 | 0.030 |
Why?
|
Monitoring, Physiologic | 3 | 1991 | 1780 | 0.030 |
Why?
|
Indoles | 1 | 2004 | 1824 | 0.030 |
Why?
|
Child | 7 | 2020 | 79782 | 0.030 |
Why?
|
Sports | 1 | 2002 | 699 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11063 | 0.030 |
Why?
|
Stereotaxic Techniques | 1 | 1998 | 549 | 0.030 |
Why?
|
Nicotinic Agonists | 1 | 1998 | 265 | 0.030 |
Why?
|
Mitochondria | 1 | 2009 | 3583 | 0.030 |
Why?
|
Length of Stay | 1 | 2009 | 6384 | 0.030 |
Why?
|
Apoptosis | 1 | 2011 | 9466 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 1998 | 448 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1545 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 1998 | 459 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3799 | 0.030 |
Why?
|
Radiosurgery | 2 | 2019 | 1341 | 0.030 |
Why?
|
Receptors, Nicotinic | 1 | 1998 | 495 | 0.030 |
Why?
|
Hypothalamus | 1 | 1999 | 998 | 0.030 |
Why?
|
Patient Transfer | 1 | 2021 | 774 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2208 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2000 | 12761 | 0.030 |
Why?
|
Blood Flow Velocity | 3 | 2002 | 1370 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 1998 | 755 | 0.030 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2013 | 31 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58558 | 0.030 |
Why?
|
Hemodynamics | 1 | 2003 | 4156 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2022 | 2052 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 1113 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1998 | 892 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2003 | 1649 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2019 | 1263 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2007 | 12951 | 0.030 |
Why?
|
Fever | 1 | 1999 | 1617 | 0.020 |
Why?
|
Angiography | 2 | 2005 | 1598 | 0.020 |
Why?
|
Trauma Centers | 1 | 2017 | 933 | 0.020 |
Why?
|
Cervical Vertebrae | 2 | 2009 | 977 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2009 | 3593 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20037 | 0.020 |
Why?
|
Argon | 2 | 1987 | 36 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 9163 | 0.020 |
Why?
|
Intracranial Arteriosclerosis | 1 | 1992 | 136 | 0.020 |
Why?
|
Regression Analysis | 1 | 2021 | 6337 | 0.020 |
Why?
|
Surgical Wound Dehiscence | 1 | 1992 | 213 | 0.020 |
Why?
|
Medicare Part A | 1 | 2011 | 40 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2017 | 1474 | 0.020 |
Why?
|
Child, Preschool | 3 | 2018 | 42045 | 0.020 |
Why?
|
Median Nerve | 1 | 1991 | 132 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1384 | 0.020 |
Why?
|
Logistic Models | 2 | 2018 | 13221 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2018 | 26176 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 2 | 2001 | 239 | 0.020 |
Why?
|
Thoracic Vertebrae | 2 | 2009 | 595 | 0.020 |
Why?
|
Neck | 1 | 2015 | 731 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2011 | 293 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2013 | 592 | 0.020 |
Why?
|
Blood Gas Analysis | 2 | 2002 | 377 | 0.020 |
Why?
|
Intraoperative Period | 1 | 1991 | 511 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3562 | 0.020 |
Why?
|
Signal Transduction | 1 | 2013 | 23335 | 0.020 |
Why?
|
Melanoma | 1 | 2008 | 5689 | 0.020 |
Why?
|
Arachnoid | 1 | 1989 | 50 | 0.020 |
Why?
|
Meningioma | 1 | 1998 | 1217 | 0.020 |
Why?
|
Saphenous Vein | 1 | 1992 | 517 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4845 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1645 | 0.020 |
Why?
|
Incidence | 2 | 2022 | 21217 | 0.020 |
Why?
|
Meningeal Neoplasms | 1 | 1998 | 1247 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2011 | 597 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15781 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1998 | 3379 | 0.020 |
Why?
|
Caspase 1 | 1 | 2009 | 226 | 0.020 |
Why?
|
Orchiectomy | 2 | 2002 | 463 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2009 | 411 | 0.020 |
Why?
|
Mitochondrial Membranes | 1 | 2009 | 172 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5483 | 0.020 |
Why?
|
Staining and Labeling | 2 | 2003 | 1083 | 0.020 |
Why?
|
Patient Care Team | 1 | 1999 | 2505 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3861 | 0.020 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2008 | 102 | 0.020 |
Why?
|
Hospital Charges | 1 | 2009 | 351 | 0.020 |
Why?
|
Fractures, Bone | 1 | 1979 | 2039 | 0.020 |
Why?
|
Endarterectomy, Carotid | 1 | 1992 | 549 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 1998 | 2211 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 11890 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5638 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54092 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1992 | 1486 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2009 | 1094 | 0.020 |
Why?
|
Diskectomy | 1 | 2007 | 209 | 0.020 |
Why?
|
Agnosia | 1 | 1986 | 66 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22022 | 0.020 |
Why?
|
Health Care Reform | 1 | 1994 | 1245 | 0.020 |
Why?
|
Laminectomy | 1 | 1986 | 223 | 0.020 |
Why?
|
Central Nervous System Diseases | 1 | 1989 | 519 | 0.010 |
Why?
|
Rabbits | 2 | 1987 | 4772 | 0.010 |
Why?
|
Vision Tests | 1 | 2005 | 158 | 0.010 |
Why?
|
Dogs | 2 | 1986 | 3838 | 0.010 |
Why?
|
Arteries | 2 | 2007 | 1125 | 0.010 |
Why?
|
Models, Neurological | 1 | 2012 | 1757 | 0.010 |
Why?
|
Tetrazolium Salts | 1 | 2003 | 92 | 0.010 |
Why?
|
Mice | 5 | 2013 | 81066 | 0.010 |
Why?
|
Evoked Potentials, Auditory | 1 | 1987 | 529 | 0.010 |
Why?
|
Cysts | 1 | 1989 | 681 | 0.010 |
Why?
|
Eye Diseases | 1 | 1989 | 651 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2011 | 20992 | 0.010 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2005 | 461 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2009 | 995 | 0.010 |
Why?
|
Reaction Time | 2 | 1987 | 2076 | 0.010 |
Why?
|
Drug Utilization | 1 | 2009 | 1187 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14637 | 0.010 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2005 | 397 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2005 | 632 | 0.010 |
Why?
|
Cell Survival | 2 | 2002 | 5781 | 0.010 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2005 | 425 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 4565 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 21990 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2007 | 1005 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 29488 | 0.010 |
Why?
|
Estrogen Receptor beta | 1 | 2002 | 168 | 0.010 |
Why?
|
Immunoblotting | 1 | 2005 | 1647 | 0.010 |
Why?
|
Optic Nerve | 1 | 2005 | 567 | 0.010 |
Why?
|
Drug Implants | 1 | 2002 | 230 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2002 | 1141 | 0.010 |
Why?
|
Central Nervous System | 1 | 2008 | 1332 | 0.010 |
Why?
|
Speech Perception | 1 | 1986 | 505 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4046 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9514 | 0.010 |
Why?
|
Intracranial Pressure | 1 | 1982 | 324 | 0.010 |
Why?
|
Permeability | 1 | 2002 | 718 | 0.010 |
Why?
|
Neurodegenerative Diseases | 1 | 2009 | 1081 | 0.010 |
Why?
|
Tomography, X-Ray | 1 | 1979 | 60 | 0.010 |
Why?
|
Visual Acuity | 1 | 1989 | 2642 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 1966 | 0.010 |
Why?
|
Paresthesia | 1 | 1980 | 162 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5856 | 0.010 |
Why?
|
Motor Skills | 1 | 2002 | 520 | 0.010 |
Why?
|
Caspases | 1 | 2002 | 876 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2005 | 1073 | 0.010 |
Why?
|
Estrogen Receptor alpha | 1 | 2002 | 580 | 0.010 |
Why?
|
Temporal Lobe | 1 | 1986 | 1688 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10075 | 0.010 |
Why?
|
Functional Laterality | 1 | 2005 | 2252 | 0.010 |
Why?
|
Cell Line | 2 | 2002 | 15587 | 0.010 |
Why?
|
Benzylidene Compounds | 1 | 1998 | 23 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29929 | 0.010 |
Why?
|
Drug Carriers | 1 | 2002 | 705 | 0.010 |
Why?
|
Reflex | 1 | 1999 | 376 | 0.010 |
Why?
|
Sacrum | 1 | 1979 | 276 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 1981 | 442 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2002 | 2469 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2002 | 748 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1998 | 2090 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2000 | 1841 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2002 | 1167 | 0.010 |
Why?
|
Olfactory Bulb | 1 | 1998 | 198 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12684 | 0.010 |
Why?
|
Body Temperature | 1 | 1999 | 777 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8512 | 0.010 |
Why?
|
Blindness | 1 | 1980 | 582 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13597 | 0.010 |
Why?
|
Suture Techniques | 1 | 2000 | 771 | 0.010 |
Why?
|
Dinoprostone | 1 | 1998 | 598 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3257 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2008 | 4159 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 2 | 1987 | 939 | 0.010 |
Why?
|
Coronary Vessels | 1 | 1986 | 3072 | 0.010 |
Why?
|
Recurrence | 1 | 1986 | 8426 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6371 | 0.010 |
Why?
|
Plasmids | 1 | 1998 | 2275 | 0.010 |
Why?
|
Drug Combinations | 1 | 1998 | 2020 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4602 | 0.010 |
Why?
|
Coronary Disease | 1 | 1986 | 5915 | 0.010 |
Why?
|
Morbidity | 1 | 1996 | 1748 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10749 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1996 | 1668 | 0.010 |
Why?
|
Transfection | 1 | 1998 | 5777 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1998 | 6070 | 0.000 |
Why?
|
Necrosis | 1 | 1992 | 1604 | 0.000 |
Why?
|
Sex Characteristics | 1 | 1998 | 2621 | 0.000 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1986 | 80 | 0.000 |
Why?
|
Disabled Persons | 1 | 1996 | 1224 | 0.000 |
Why?
|
Pyridines | 1 | 1998 | 2864 | 0.000 |
Why?
|
Radioimmunoassay | 1 | 1986 | 866 | 0.000 |
Why?
|
Critical Care | 1 | 1996 | 2690 | 0.000 |
Why?
|
Platelet Aggregation | 1 | 1986 | 773 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1998 | 18936 | 0.000 |
Why?
|
Aorta | 1 | 1987 | 2037 | 0.000 |
Why?
|
Syndrome | 1 | 1986 | 3261 | 0.000 |
Why?
|
Quality of Life | 1 | 1996 | 13263 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1979 | 1263 | 0.000 |
Why?
|
Seizures | 1 | 1979 | 2919 | 0.000 |
Why?
|